Abstract
A feature of epileptogenesis is burst firing of individual neurons. The burst comprises a slow paroxysmal depolarizing ion shift (PDS) upon which is superimposed a train of action potentials [6, 36]. Bursting depends largely on influx of Ca2+, although other ionic currents are also involved [37, 56].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ashton D (1983) Bicuculline seizure thresholds, actions of diazepam, pentobarbital and etomidate isomers alone and in combination with Ro 15-1788, Picrotoxin and (±) DMBB. Eur J Pharmacol 94:319–325
Ashton D, Wauquier A (1979a) Effects of some anti-epileptic, neuroleptic and gabaminergic drugs on convulsions induced by d,l-allylglycine. Pharmacol Biochem Behav 11:221–226
Ashton D, Wauquier A (1979b) Behavioural analysis of the effects of 15 anticonvulsants in amygdaloid kindled rats. Psychopharmacology 65:7–13
Ashton D, Wauquier A (1985) Modulations of a gaba-ergic inhibitory circuit in the in vitro hippocampus by etomidate isomers. Anaesth Analg 64:975–980
Ashton D, Marannes R, Pauwels PJ, Van Belle H, Reid K, Wauquier A (1986) Possible mechanisms of flunarizine’s anticonvulsant activity. Health Science Review: International Workshop on Flunarizine in Epilepsy, Beerse, 24 May 1985, p 45–59
Ayala GF, Dichter M, Gumnit RZ, Matsumoto H, Spencer WA (1973) Genesis of epileptic interictal spikes: new knowledge of cortical feedback systems suggest a neurophysiological explanation of brief paroxysms. Brain Res 211:227–234
Bergamasco B, Cantello R, Riccio A (1987) Utilita della flunarizina come coordiuvante nel trattamento dell’epilessia (confronto in doppio cieco con un placebo in disegno cross over) (unpublished report)
Bidard JN, Vijverberg HPM, Frelin C, Chungue E, Legrand A-M, Bagnis R, Ladunski M (1984) Cignatoxin is a novel type of Na+ channel toxin. J Biol Chem 259:8253–8357
Bingmann D, Speckmann EJ (1984) Paroxysmal depolarization shifts in neurons of hippocampal slices: depression by calcium antagonists. Pflugers Arch S402, R29
Binnie CD, de Beukelaar F, Meijer JWA, Meinardi H, Overweg J, Wauquier A, van Wieringen A (1985) Open dose-ranging trial of flunarizine as add-on therapy in epilepsy. Epilepsia 26:424–428
Caspers H, Speckmann EJ, Lehmkühler A (1980) Electrogenesis of cortical DC potentials. In: Kornhuber HH, Deecke L (eds) Motivation motor and sensory processes of the brain: electrical potentials, behaviour and clinical use. Prog Brain Res 54:3–15
Cavazzuti GB, Galli V, Benatti A (1986) The use of flunarizine in pediatric epilepsy. Funct Neurol 1:551–554
Curatolo P, Bruni O, Brindesi I, Pruna D, Cusmai R (1986) La flunarizina nelle epilessie formaco-resistenti deH’infanzia e dell’adolescenza. Riv Neurol 56:25–38
Debandt R, De Smedt R, Jorens H, Leysen M, Rodrigus E, Van Eycken L (1985) Flunarizine as “add-on” therapy in institutionalized patients with refractory epilepsy. Effect on seizure incidence and behaviour. Janssen Research Product Information Service: CRR R 14950/65
Declerck AC, Wauquier A (1978) Double-blind study on the effectiveness on flunarizine in therapy-resistant epilepsy in mentally retarded children (abstr). 10th Epilepsy International Symposium, p 169
Declerck AC, Wauquier A (1983) Flunarizine, a double-blind study in therapy resistant mentally retarded epileptic children. Suppl Boll Chim Farm 122:9CL–16CL
Declerck AC, Oei LT, Wauquier A (1986) Flunarizine in mentally retarded children with therapy-resistant epilepsy. Health Science Review: International Workshop of Flunarizine in Epilepsy, Beerse, 24 May 1985, p 68
De Domenico P, Gallitto G, Musolino R, Di Perri R (1987) Saggio dell “Utilita” condiuvante della flunarizina in epilettia gravi (unpublished report)
De Sarro GB, Nistico G, Meldrum B (1986) Anticonvulsant properties of flunarizine on reflex and generalised models of epilepsy. Neuropharmacology 25:695–701
De Sarro GB, Meldrum BS, Nistico G (1988) Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol 93:247–256
Desmedt LKC, Niemegeers CJE, Janssen PAJ (1975) Anticonvulsant properties of cinnarizine and flunarizine in rats and mice. Arzneimittelforschung 25:1408–1413
Fröscher W, Bülau P, Burr W et al. (1988) Double-blind, placebo-controlled trial in flunarizine in therapy-resistant persons with epilepsy. Clin Neuropharmacol (in press)
Giroud M, Nivelon JL, Dumas R (1987) Antiepileptic activity of flunarizine in 10 therapy-resistant children with epilepsy. Presse Med 16:913
Heinemann U, Lux HA, Gutnick MJ (1977) Extracellular free calcium and potassium during paroxysmal activity in the cerebral cortex of the rat. Exp Brain Res 27:237–243
Heykants J, De Cree J, Hörig C (1979) Steady-state plasma levels of flunarizine in chronically treated patients. Arzneimittelforschung 29:1168–1171
Keene D, Whiting S, Humphreys P, Findlay HP, Cumming B (1987) Flunarizine, an add-on drug in the treatment of refractory childhood epilepsy. XXIInd Canadian congress of neurological sciences. Vancouver, June 1987
Konishi T, Murakami M, Yamatani M, Koda O, Okada T, Seto H, Nitani T (1987) Efficiency of flunarizine (a calcium entry blocker in therapy resistant epileptic children with partial epilepsy). The 20th Congress of the Japanese Society of Epilepsy: Abstract Book, p 131
Mancia D (1987) La flunarizina come coordiuvante della terapia di base nel trattamento dell’epilessia (Studio clinico controllato) (unpublished report)
Meldrum BS (1979) Convulsant drugs, anticonvulsants and GABA-mediated neuronal inhibition. In: Krogsgaard-Larsen P, Scheel-Kruger J, Kofod H (eds) Gaba-neurotransmitters. Munksgaard, Copenhagen, pp 390–405
Meldrum BS (1983) Convulsants and anticonvulsant drug mechanisms. In: Baldy-Moulinier M, Ingvar DH, Meldrum BS (eds) Current problems in epilepsy. Libbey, London, pp 324–336
Moglia A, Bergamasco B, Di Perri R, Mancia D (1986) Flunarizine as add-on therapy in epilepsy, cross over study versus placebo. Furet Neurol 1:547–550
Olsen RW (1982) Drug interactions at the GABA-receptor ionophore complex. Annu Rev Pharmacol Toxicol 22:245–277
Overweg J (1987) Safety evaluation of flunarizine after long-term “add-on” administration in epileptic patients. Janssen Research Product Information Service, Clinical Research Report, R14 950/71
Overweg J, Binnie CD, Meijer JWA, Meinardi H, Nuijten STM, Schmaltz S, Wauquier A (1984) Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy. Epilepsia 25:217–222
Pothmann R, Braumann G, Kröger T (1986) Calciumeintrittsblockade als Zusatz-Behandlung bei therapieresistenten kindlichen Epilepsien. Deutsche Sektion der Internationalen Liga gegen Epilepsie: 26. Jahrestagung, Münster, Abstract, p 56
Prince DA (1978) Neurophysiology of epilepsy. Annu Rev Neurosci 1:395–415
Prince DA (1982) Epileptogenesis in hippocampal and neocortical neurones. In: Klee MR, Lux HD, Speckman EJ (eds) Physiology and pharmacology of epileptogenic phenomena. Raven, New York, pp 151–161
Sorel L (1987) La flunarizine dans l’epilepsie: evaluation d’un traitement “additif” de quatre nous chez des patients resistant au traitement antiépileptique existant. Acta Neurol Belg 87:140–147
Starreveld E et al. Flunarizine in epilepsy (in preparation)
Study RE, Barker JL (1981) Diazepam and (—) pentobarbital: fluctuation analysis reveals different mechanisms for the potentiation of G AB A responses in cultured central neurones. Proc Natl Acad Sci USA 78:7180–7184
Takahashi T (1988) An open trial of flunarizine hydrochloride as add-on treatment in therapy-resistant epileptics. Clin Psychiatry (in press)
Tata MR, Guizzaro A, Giudici S, Parisi A, Bravaccio F (1987) Flunarizine in pharmacoresistant epilepsies: preliminary experiences in 30 cases. International Symposium on Calcium Antagonists, Pharmacology and Clinical Research, New York City, 10–13 February 1987, p 113
Touquet G, Van Cappel F (1985) Flunarizine as adjuvants in therapy resistant epilepsy, a double-blind placebo-controlled trial. Janssen Research Product Information Service, Clinical Research Report No. 14950/64
Treiman DM, De Giorgio CM, Cornish JW, Cereghino JJ (1986) Efficacy and toxicity of flunarizine in partial onset seizures at concentrations of 30, 60,120 ng/ml. Epilepsia 27:649–650
Treiman DM, Tsay J-Y, Whitley LP, Seaman CA, Kupferberg HJ, Pledger GW, Cereghino JJ (1987) Final report of flunarizine open tolerability study. Epilepsy Res NINCDS, Bethesda
Umezawa Y, Amano K, Kawamurah H et al. (1987) Add-on therapy of flunarizine in therapy-resistant epilepsy. The 20th Congress of the Japanese Society of Epilepsy. Abstract Book p 92
Van Bever W (1974) Acute oral toxicity (LD50) of flunarizine dihydrochloride in mice, rats and guinea pigs. Janssen Pharmaceutica, Preclinical Research Report R14950/1 December 1974
Van Wieringen A, Ashton D, De Beukelaar F, Binnie CD, Overweg J, Wauquier A (1986) Flunarizine in the treatment of epilepsy. In: Schalse H, Walden J (eds) Epilepsy and calcium. Urban & Schwartzenberg, Munich, pp 387–399
Walden J, Speckmann EJ, Witte OW (1984) Effects of the calcium antagonist verapamil on spontaneous and evoked bioelectric activity on the cerebral cortex. Pflugers Arch 402:R36
Walden J, Speckmann EJ, Witte OW (1985) Suppression of focal epileptiform discharges by intracerebroventricular perfusion of a calcium antagonist. Electroencephalogr Clin Neurophysiol 61:299–309
Wauquier A, Ashton D, Melis W (1979) Behavioural analysis of amygdaloid kindling in Beagle dogs and the effects of clonazepam, diazepam, phénobarbital, diphenylhydantoin and flunarizine on seizure manifestation. Exp Neurol 64:579–586
Wauquier A, Ashton D, Clincke G, Fransen J, Gillardin JM, Janssen PAJ (1986) Anticonvulsant profile of flunarizine. Drug Dev Res 7:49–60
Willow M, Catterall WA (1982) Inhibition of binding of [3H] batrachotoxin in A-20-α-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 22:627–635
Witte OW, Walden J, Speckmann EJ, Elger CE (1983) Reduction of penicillin-induced paroxysmal depolarization shifts in neurons of rat cerebral cortex by intracellular injection of calcium channel blocker. Neurosci Lett Suppl 14:S405
Witte OW, Speckmann EJ, Walden J (1984) Contribution of calcium and calcium-dependent membrane currents to epileptic discharges in neocortical neurons of the rat. Cell Calcium 5:311
Wong RKS, Prince DA, Basbaum AI (1979) Dendritic mechanisms underlying penicillin induced epileptiform activity. Science 204:1228–1231
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Binnie, C.D., de Beukelaar, F., Overweg, J. (1989). Review of Flunarizine in Epilepsy. In: Hartmann, A., Kuschinsky, W. (eds) Cerebral Ischemia and Calcium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85863-5_61
Download citation
DOI: https://doi.org/10.1007/978-3-642-85863-5_61
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85865-9
Online ISBN: 978-3-642-85863-5
eBook Packages: Springer Book Archive